Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
The accelerated approval is supported by results from part 1 of the ESSENCE trial
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Subscribe To Our Newsletter & Stay Updated
